| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Carboxypeptidase, vitellogenic-like (CPVL), transcript variant 1 from ORIGENE TECHNOLOGIES | LY410561 | 100 ug | ORIGENE TECHNOLOGIES |
| Carboxypeptidase, vitellogenic-like (CPVL), transcript variant 2 from ORIGENE TECHNOLOGIES | LY412799 | 100 ug | ORIGENE TECHNOLOGIES |
| Carboxypeptidase X (M14 family), member 1 (CPXM1) from ORIGENE TECHNOLOGIES | LY412734 | 100 ug | ORIGENE TECHNOLOGIES |
| Carboxypeptidase X (M14 family), member 1 (CPXM1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY433406 | 100 ug | ORIGENE TECHNOLOGIES |
| Carboxypeptidase Z (CPZ), transcript variant 2 from ORIGENE TECHNOLOGIES | LY401209 | 100 ug | ORIGENE TECHNOLOGIES |
| Carboxypeptidase Z (CPZ), transcript variant 3 from ORIGENE TECHNOLOGIES | LY423071 | 100 ug | ORIGENE TECHNOLOGIES |
| Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) (CEACAM1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY433126 | 100 ug | ORIGENE TECHNOLOGIES |
| Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) (CEACAM1), transcript variant 4 from ORIGENE TECHNOLOGIES | LY433069 | 100 ug | ORIGENE TECHNOLOGIES |
| Carcinoembryonic antigen-related cell adhesion molecule 16 (CEACAM16) from ORIGENE TECHNOLOGIES | LY422030 | 100 ug | ORIGENE TECHNOLOGIES |
| Carcinoembryonic antigen-related cell adhesion molecule 18 (CEACAM18) from ORIGENE TECHNOLOGIES | LY421622 | 100 ug | ORIGENE TECHNOLOGIES |
| Carcinoembryonic antigen-related cell adhesion molecule 3 (CEACAM3) from ORIGENE TECHNOLOGIES | LY419723 | 100 ug | ORIGENE TECHNOLOGIES |
| Carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4) from ORIGENE TECHNOLOGIES | LY400693 | 100 ug | ORIGENE TECHNOLOGIES |
| Carcinoembryonic antigen-related cell adhesion molecule 7 (CEACAM7) from ORIGENE TECHNOLOGIES | LY402055 | 100 ug | ORIGENE TECHNOLOGIES |
| Carcinoembryonic antigen-related cell adhesion molecule 8 (CEACAM8) from ORIGENE TECHNOLOGIES | LY419724 | 100 ug | ORIGENE TECHNOLOGIES |
| Carcinoembryonic antigen-related cell adhesion molecule 19 (CEACAM19), transcript variant 1 from ORIGENE TECHNOLOGIES | LY426880 | 100 ug | ORIGENE TECHNOLOGIES |
| Carcinoembryonic antigen-related cell adhesion molecule 19 (CEACAM19), transcript variant 2 from ORIGENE TECHNOLOGIES | LY412583 | 100 ug | ORIGENE TECHNOLOGIES |
| Carcinoembryonic antigen-related cell adhesion molecule 21 (CEACAM21), transcript variant 2 from ORIGENE TECHNOLOGIES | LY409494 | 100 ug | ORIGENE TECHNOLOGIES |
| Carcinoembryonic antigen-related cell adhesion molecule 20 (CEACAM20), transcript variant 4L from ORIGENE TECHNOLOGIES | LY420168 | 100 ug | ORIGENE TECHNOLOGIES |
| Carcinoembryonic antigen-related cell adhesion molecule 20 (CEACAM20), transcript variant 5L from ORIGENE TECHNOLOGIES | LY420166 | 100 ug | ORIGENE TECHNOLOGIES |
| Carcinoembryonic antigen-related cell adhesion molecule 20 (CEACAM20), transcript variant 4S from ORIGENE TECHNOLOGIES | LY420167 | 100 ug | ORIGENE TECHNOLOGIES |
| Carcinoembryonic antigen-related cell adhesion molecule 20 (CEACAM20), transcript variant 5S from ORIGENE TECHNOLOGIES | LY420169 | 100 ug | ORIGENE TECHNOLOGIES |
| CARD14 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN217455 | 1 kit | ORIGENE TECHNOLOGIES |
| CARD14 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN217455BN | 1 kit | ORIGENE TECHNOLOGIES |
| CARD14 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN217455LP | 1 kit | ORIGENE TECHNOLOGIES |
| CARD14 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN217455RB | 1 kit | ORIGENE TECHNOLOGIES |
| CARD10 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN217652 | 1 kit | ORIGENE TECHNOLOGIES |
| CARD10 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN217652BN | 1 kit | ORIGENE TECHNOLOGIES |
| CARD10 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN217652LP | 1 kit | ORIGENE TECHNOLOGIES |
| CARD10 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN217652RB | 1 kit | ORIGENE TECHNOLOGIES |
| CARD11 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN222740 | 1 kit | ORIGENE TECHNOLOGIES |
| CARD11 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN222740LP | 1 kit | ORIGENE TECHNOLOGIES |
| CARD11 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN222740BN | 1 kit | ORIGENE TECHNOLOGIES |
| CARD11 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN222740RB | 1 kit | ORIGENE TECHNOLOGIES |
| Cardiolipin synthase 1 (CRLS1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426793 | 100 ug | ORIGENE TECHNOLOGIES |
| Cardiolipin synthase 1 (CRLS1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412754 | 100 ug | ORIGENE TECHNOLOGIES |
| Cardiotrophin-like cytokine factor 1 (CLCF1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY402229 | 100 ug | ORIGENE TECHNOLOGIES |
| CARD19 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN402608 | 1 kit | ORIGENE TECHNOLOGIES |
| Cardiotrophin-like cytokine factor 1 (CLCF1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY431793 | 100 ug | ORIGENE TECHNOLOGIES |
| CARD6 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN410848 | 1 kit | ORIGENE TECHNOLOGIES |
| CARD8 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN411512 | 1 kit | ORIGENE TECHNOLOGIES |
| CARD16 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN411537 | 1 kit | ORIGENE TECHNOLOGIES |
| CARD9 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN415899 | 1 kit | ORIGENE TECHNOLOGIES |
| CARD14 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN417455 | 1 kit | ORIGENE TECHNOLOGIES |
| CARD10 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN417652 | 1 kit | ORIGENE TECHNOLOGIES |
| Human retinol binding protein 2, cellular (RBP2) from ORIGENE TECHNOLOGIES | TP317970 | 20 ug | ORIGENE TECHNOLOGIES |
| Human retinol binding protein 5, cellular (RBP5) from ORIGENE TECHNOLOGIES | TP305891 | 20 ug | ORIGENE TECHNOLOGIES |
| Human retinol binding protein 7, cellular (RBP7) from ORIGENE TECHNOLOGIES | TP309035 | 20 ug | ORIGENE TECHNOLOGIES |
| Human retinol binding protein 1, cellular (RBP1), transcript variant 1 from ORIGENE TECHNOLOGIES | TP314515 | 20 ug | ORIGENE TECHNOLOGIES |
| Human retinol binding protein 3, interstitial (RBP3) from ORIGENE TECHNOLOGIES | TP308063 | 20 ug | ORIGENE TECHNOLOGIES |
| Human retinol binding protein 4, plasma (RBP4) from ORIGENE TECHNOLOGIES | TP720147 | 10 ug | ORIGENE TECHNOLOGIES |